Literature DB >> 26027696

Antibody-Drug Conjugates (ADCs): Magic Bullets at Last!

John M Lambert1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26027696     DOI: 10.1021/acs.molpharmaceut.5b00302

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Evolution of the Systems Pharmacokinetics-Pharmacodynamics Model for Antibody-Drug Conjugates to Characterize Tumor Heterogeneity and In Vivo Bystander Effect.

Authors:  Aman P Singh; Gail M Seigel; Leiming Guo; Ashwni Verma; Gloria Gao-Li Wong; Hsuan-Ping Cheng; Dhaval K Shah
Journal:  J Pharmacol Exp Ther       Date:  2020-04-09       Impact factor: 4.030

2.  Reconstruction of 3D structures of MET antibodies from electron microscopy 2D class averages.

Authors:  Qi Chen; Michal Vieth; David E Timm; Christine Humblet; Dina Schneidman-Duhovny; Ilan E Chemmama; Andrej Sali; Wei Zeng; Jirong Lu; Ling Liu
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

3.  A Cell-Level Systems PK-PD Model to Characterize In Vivo Efficacy of ADCs.

Authors:  Aman P Singh; Leiming Guo; Ashwni Verma; Gloria Gao-Li Wong; Dhaval K Shah
Journal:  Pharmaceutics       Date:  2019-02-25       Impact factor: 6.321

4.  Increasing the Potential of the Auristatin Cancer-Drug Family by Shifting the Conformational Equilibrium.

Authors:  Iris K Sokka; Filip S Ekholm; Mikael P Johansson
Journal:  Mol Pharm       Date:  2019-06-28       Impact factor: 4.939

5.  Co-administered antibody improves penetration of antibody-dye conjugate into human cancers with implications for antibody-drug conjugates.

Authors:  Guolan Lu; Naoki Nishio; Nynke S van den Berg; Brock A Martin; Shayan Fakurnejad; Stan van Keulen; Alexander D Colevas; Greg M Thurber; Eben L Rosenthal
Journal:  Nat Commun       Date:  2020-11-09       Impact factor: 14.919

Review 6.  Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.

Authors:  Rotimi Sheyi; Beatriz G de la Torre; Fernando Albericio
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

7.  An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.

Authors:  Victor Pallarès; Ugutz Unzueta; Aïda Falgàs; Laura Sánchez-García; Naroa Serna; Alberto Gallardo; Gordon A Morris; Lorena Alba-Castellón; Patricia Álamo; Jorge Sierra; Antonio Villaverde; Esther Vázquez; Isolda Casanova; Ramon Mangues
Journal:  J Hematol Oncol       Date:  2020-04-15       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.